Skip to main content

Basics of Chimeric Antigen Receptor (CAR) Immunotherapy

  • 1st Edition - July 19, 2019
  • Author: Mumtaz Y. Balkhi
  • Language: English
  • Paperback ISBN:
    9 7 8 - 0 - 1 2 - 8 1 9 5 7 3 - 4
  • eBook ISBN:
    9 7 8 - 0 - 1 2 - 8 1 9 7 4 7 - 9

Basics of Chimeric Antigen Receptor (CAR) Immunotherapy presents the latest on how T cell adoptive immunotherapy has progressed in its ultimate goal of curing metastatic malignant… Read more

Basics of Chimeric Antigen Receptor (CAR) Immunotherapy

Purchase options

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Book bundle cover eBook and print

Institutional subscription on ScienceDirect

Request a sales quote

Basics of Chimeric Antigen Receptor (CAR) Immunotherapy presents the latest on how T cell adoptive immunotherapy has progressed in its ultimate goal of curing metastatic malignant cancers. Recent clinical data obtained with checkpoint receptor blockade inhibitors and chimeric antigen receptor (CAR) therapy has been especially promising, thus generating renewed hope that we may be on the verge of finally curing cancer. Over the years, huge progress has been made in controlling several stage IV metastasized cancers through the clinical application of checkpoint receptor inhibitory drugs and CAR-Therapy that has seen unprecedented interest in the immunotherapy field.